Biotest Aktiengesellschaft (ETR: BIO3)
Germany
· Delayed Price · Currency is EUR
27.60
+0.10 (0.36%)
Jan 17, 2025, 5:36 PM CET
ETR: BIO3 Employees
Biotest Aktiengesellschaft had 2,426 employees as of December 31, 2023. The number of employees increased by 198 or 8.89% compared to the previous year.
Employees
2,426
Change (1Y)
198
Growth (1Y)
8.89%
Revenue / Employee
€291,426
Profits / Employee
€28,236
Market Cap
1.37B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Merck KGaA | 62,908 |
Siemens Healthineers AG | 72,000 |
Bayer Aktiengesellschaft | 96,931 |
Fresenius SE & Co. KGaA | 193,865 |
Sartorius Aktiengesellschaft | 14,614 |
Fresenius Medical Care AG | 119,845 |
Carl Zeiss Meditec AG | 5,730 |
SCHOTT Pharma AG & Co. KGaA | 4,690 |
Biotest Aktiengesellschaft News
- 11 days ago - Biotest's Big Step: FDA Review for Fibrinogen Biologics - Wallstreet:Online
- 11 days ago - EQS-News: Important milestone for Biotest: Biologics License Application for Fibrinogen submitted to the US Food and Drug Administration (FDA) - Wallstreet:Online
- 2 months ago - EQS-News: Minister of Economic Affairs Mansoori and Lord Mayor Benz visit Biotest's plasma center in Darmstadt and call for plasma donations - Wallstreet:Online
- 2 months ago - Biotest Boosts Revenue by 4.5% to €523M in First 9 Months! - Wallstreet:Online
- 2 months ago - EQS-News: Biotest increases revenues in the first 9 months by 4.5% to Euro 523 million - Wallstreet:Online
- 2 months ago - Biotest AG: Revenue & Cash Flow Forecast Cut, EBIT Guidance Steady - Wallstreet:Online
- 2 months ago - EQS-Adhoc: Biotest AG: Biotest corrects forecast for revenue, cash flow and ROCE – EBIT guidance unchanged - Wallstreet:Online
- 3 months ago - Kedrion and Biotest complete long-term Exclusive Distribution Agreement for Yimmugo® in the US - Benzinga